Compare CASY & ALC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CASY | ALC |
|---|---|---|
| Founded | 1959 | 1945 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Diversified Commercial Services | Ophthalmic Goods |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 30.9B | 32.4B |
| IPO Year | 1994 | 2002 |
| Metric | CASY | ALC |
|---|---|---|
| Price | $756.09 | $70.50 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 12 |
| Target Price | ★ $696.50 | $89.38 |
| AVG Volume (30 Days) | 290.8K | ★ 1.6M |
| Earning Date | 06-08-2026 | 05-05-2026 |
| Dividend Yield | ★ 0.29% | 0.25% |
| EPS Growth | ★ 30.87 | N/A |
| EPS | ★ 19.16 | N/A |
| Revenue | ★ $17,561,101,000.00 | N/A |
| Revenue This Year | $9.54 | $7.99 |
| Revenue Next Year | $5.34 | $6.38 |
| P/E Ratio | $39.57 | ★ $38.31 |
| Revenue Growth | ★ 10.16 | N/A |
| 52 Week Low | $497.38 | $61.84 |
| 52 Week High | $927.85 | $87.64 |
| Indicator | CASY | ALC |
|---|---|---|
| Relative Strength Index (RSI) | 35.77 | 51.27 |
| Support Level | $734.18 | $66.08 |
| Resistance Level | $774.23 | $82.13 |
| Average True Range (ATR) | 26.51 | 1.12 |
| MACD | -8.98 | -0.34 |
| Stochastic Oscillator | 12.72 | 25.21 |
Casey's General Stores Inc, along with its subsidiaries, operates convenience stores mainly under the names Casey's, GoodStop (by Casey's), and Casey's General Store throughout various states in the USA, approximately half of which are located in Iowa, Missouri, and Illinois. These stores offer a broad selection of food items (which includes prepared foods such as regular and breakfast pizza, donuts, hot breakfast items, and hot and cold sandwiches), beverages, tobacco and nicotine products, groceries, health and beauty aids, automotive products, and other non-food items. The majority of the company's revenue is mainly derived from the retail sale of fuel and the products offered inside its stores.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.